a San Marino 100 new cases per year
The November 14 and the World Diabetes Day and the volunteers of the association “To live better” have made themselves available to citizens with a listening space at the Atlante Shopping Center to answer questions about the disease and also to measure glycemia. As the Iss 100 new cases of diabetes mellitus are recorded every year in San Marino. On the whole, diabetic patients are on the Titan 2,513. The ISS recommends the importance of vaccination against influenza and Covid, as people with diabetes fall into categories a risk.
A century after its discovery, theinsulin A key drug for the treatment of diabetes is still out of reach for millions of people with diabetes. This is what theWorld Health Organization in a report published on the occasion of this anniversary. Diabetes is a disease characterized by high blood sugar levels which, over time, can stress severe damage to the heart, blood vessels, eyes, kidneys and nerves. Serious that can only be countered by taking insulin. ” The 100 pharmacists who discovered this result years ago refused to profit from their discovery and they sold the patent for a single dollar“, he recalled Tedros Adhanom Ghebreyesus, director general of the United Nations agency. “Unfortunately, this gesture of solidarity was overtaken by a multi-billion dollar business which has created vast gaps in access to the drug, “he added, especially in developing countries. For nine million people around the world living with type 1 diabetes, juvenile diabetes, a chronic disease in which the pancreas produces little or no, taking the drug turns the disease into a manageable state. and for which insulin is essential to reduce the risk of kidney failure, blindness And amputation. However, as WHO notes, one in two people who need this drug do not get it. The reason, as WHO explains, is that global markets have shifted from human insulin, which can be produced at a relatively low cost, to synthetic insulins which can be up to three times more expensive. Therefore, the United Nations agency asks to improve theaffordability of insulin, regulating prices and profit margins through joint buying and greater price transparency. The goal is to fulfill the promise made 100 years ago and that is to make access to this life-saving drug universal, breaking down the barriers of high prices, low availability of human insulin, a market dominated by only a few manufacturers and weak health systems.